We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$423M
AUM Growth
-$15.2M
Cap. Flow
-$6.93M
Cap. Flow %
-1.64%
Top 10 Hldgs %
54.1%
Holding
47
New
11
Increased
12
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$10.9M
2
ABT icon
Abbott
ABT
+$9.88M
3
IQV icon
IQVIA
IQV
+$7.85M
4
QGEN icon
Qiagen
QGEN
+$7.68M
5
PFE icon
Pfizer
PFE
+$6.17M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$17.2M
2
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
3
MRK icon
Merck
MRK
+$11.9M
4
BDX icon
Becton Dickinson
BDX
+$9.14M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.53M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$50.2M 11.86%
827,901
+81,946
+11% +$4.78M
MRK icon
2
Merck
MRK
$315B
$31.3M 7.39%
260,340
-103,311
-28% -$11.9M
PFE icon
3
Pfizer
PFE
$143B
$30.6M 7.24%
1,091,385
+231,846
+27% +$6.17M
MDT icon
4
Medtronic
MDT
$107B
$24.3M 5.74%
280,682
+11,038
+4% +$1.06M
INCY icon
5
Incyte
INCY
$23.3B
$18.9M 4.46%
200,510
-18,273
-8% -$1.82M
AMGN icon
6
Amgen
AMGN
$201B
$16.6M 3.92%
47,155
-13,801
-23% -$4.92M
BIIB icon
7
Biogen
BIIB
$30.8B
$16.5M 3.9%
90,096
+4,621
+5% +$851K
ZBH icon
8
Zimmer Biomet
ZBH
$18.1B
$14.1M 3.33%
155,835
+23,357
+18% +$2.14M
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$11.6B
$13.6M 3.2%
239,918
+41,413
+21% +$2.41M
BDX icon
10
Becton Dickinson
BDX
$44.1B
$13M 3.07%
82,615
-49,761
-38% -$9.14M
ELV icon
11
Elevance Health
ELV
$80.9B
$12.9M 3.04%
43,962
+11,416
+35% +$3.75M
IONS icon
12
Ionis Pharmaceuticals
IONS
$9.03B
$12.7M 3%
169,468
-15,509
-8% -$1.22M
CAH icon
13
Cardinal Health
CAH
$53.6B
$11.6M 2.74%
54,897
-7,049
-11% -$1.52M
UNH icon
14
UnitedHealth
UNH
$384B
$9.86M 2.33%
+36,435
New +$10.9M
CVS icon
15
CVS Health
CVS
$136B
$9.72M 2.3%
135,337
-42,262
-24% -$3.26M
BRKR icon
16
Bruker
BRKR
$9.02B
$9.17M 2.17%
254,010
-687
-0.3% -$28.7K
GEHC icon
17
GE HealthCare
GEHC
$29.9B
$9M 2.12%
126,418
+12,028
+11% +$948K
ABT icon
18
Abbott
ABT
$172B
$8.99M 2.12%
+87,532
New +$9.88M
GILD icon
19
Gilead Sciences
GILD
$169B
$7.42M 1.75%
53,247
-123,167
-70% -$17.2M
LNTH icon
20
Lantheus
LNTH
$6.84B
$7.08M 1.67%
93,344
-479
-0.5% -$34.4K
IQV icon
21
IQVIA
IQV
$35.1B
$6.86M 1.62%
+40,230
New +$7.85M
SNDX icon
22
Syndax Pharmaceuticals
SNDX
$2.01B
$6.68M 1.58%
286,007
+33,945
+13% +$738K
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.05B
$6.62M 1.56%
23,750
– –
QGEN icon
24
Qiagen
QGEN
$8.56B
$6.5M 1.54%
+162,371
New +$7.68M
AVTR icon
25
Avantor
AVTR
$7.69B
$5.45M 1.29%
695,403
– –
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2026 Portfolio in Review

As of Q1 2026, Sector Gamma AS held 47 positions worth $423M, down 3.5% from $439M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sector Gamma AS's Q1 2026 filing shows 11 new, 12 increased, 16 reduced and 5 closed positions. Its largest new stake was UnitedHealth: 36,435 shares worth $9.86M. The largest sale was Gilead Sciences, an estimated $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q1 2026 buy was UnitedHealth: 36,435 shares worth $9.86M.
  • Sector Gamma AS added most to Pfizer in Q1 2026, an estimated $6.17M increase.
  • Sector Gamma AS's biggest Q1 2026 reduction was Gilead Sciences, cutting an estimated $17.2M.
  • Sector Gamma AS fully exited Thermo Fisher Scientific in Q1 2026, selling an estimated $12.6M.
  • Sector Gamma AS's ten largest holdings make up 54% of its $423M portfolio in Q1 2026.
  • Sector Gamma AS opened 11 new positions and closed 5 in Q1 2026.
  • Sector Gamma AS's portfolio value fell 3.5% quarter-over-quarter to $423M.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.